← SynDRA
TORSEMIDE
SynDRA canonical compound SYN0004098 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | SLC12A1 |
| Mechanism of action | Electrolyte reabsorption inhibitor |
| Indication | congestive heart failure | edema | hypertension |
| Disease area | cardiology |
All known targets
Mechanisms of action (all sources)
- Thromboxane receptor antagonist
- Electrolyte reabsorption inhibitor
- SLC12A1 INHIBITOR
- Sodium-(potassium)-chloride cotransporter 2 inhibitor
- SLC12A1 BLOCKER
Drug classes
- Loop Diuretic
- Antihypertensive Agents
- Cardiovascular Agents
- Diuretics
- Membrane Transport Modulators
- Natriuretic Agents
- Sodium Potassium Chloride Symporter Inhibitors
ATC classes
- C03C · HIGH-CEILING DIURETICS
Cross-references
Synonyms
- torasemide
- toradiur
- Torasemide
- Torasemide anhydrous
- Torasemida
- Luprac
- Upcard
- AC-4464
- AC4464
- BM-02.015
- BM-02015
- BM02.015
- Demadex
- Isemid
- Soaanz
- Torem 10
- Torem 2.5
- Torem 5
- Dilutol
- Presoril
- Sutril
- Toradiur
- Torasemidum
- Torem
- Torocard
- Torrem
- Unat
- Torasemide N
- Torsemide [USAN]
- AC 4464
- JDL-464
- Demadex (TN)
- Demadex, Torsemide
- GJ-1090
- KS-1123
- Luprac (TN)
- PW-2132
Reported adverse events
- Pancreatitis
- Stevens-Johnson syndrome
- Hypotension
- Ototoxicity
- Arthralgia
- Headache
- Hypersensitivity
- Angioedema
- Asthenia
- Constipation
- Cough
- Dizziness
Look up TORSEMIDE in the interactive SynDRA portal →